ORBA Wealth Advisors L.L.C. Has $1.76 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

ORBA Wealth Advisors L.L.C. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the first quarter, HoldingsChannel.com reports. The firm owned 3,362 shares of the healthcare conglomerate’s stock after selling 120 shares during the period. ORBA Wealth Advisors L.L.C.’s holdings in UnitedHealth Group were worth $1,761,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Factory Mutual Insurance Co. raised its stake in UnitedHealth Group by 5.4% during the first quarter. Factory Mutual Insurance Co. now owns 194,600 shares of the healthcare conglomerate’s stock worth $101,922,000 after acquiring an additional 10,000 shares in the last quarter. Atlas Private Wealth Advisors grew its holdings in shares of UnitedHealth Group by 6.6% during the first quarter. Atlas Private Wealth Advisors now owns 1,791 shares of the healthcare conglomerate’s stock worth $938,000 after purchasing an additional 111 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH grew its holdings in shares of UnitedHealth Group by 20.7% during the first quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 132,926 shares of the healthcare conglomerate’s stock worth $69,620,000 after purchasing an additional 22,840 shares during the last quarter. Sound Income Strategies LLC boosted its holdings in UnitedHealth Group by 15.9% in the first quarter. Sound Income Strategies LLC now owns 2,399 shares of the healthcare conglomerate’s stock valued at $1,257,000 after acquiring an additional 330 shares during the last quarter. Finally, Aries Wealth Management boosted its holdings in UnitedHealth Group by 1.5% in the first quarter. Aries Wealth Management now owns 4,407 shares of the healthcare conglomerate’s stock valued at $2,308,000 after acquiring an additional 66 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In related news, CEO Stephen J. Hemsley purchased 86,700 shares of the firm’s stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer now owns 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer now directly owns 10,398 shares of the company’s stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $313.39 on Friday. The business has a fifty day simple moving average of $386.66 and a 200 day simple moving average of $473.26. The company has a market capitalization of $284.28 billion, a PE ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the company posted $6.91 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.82%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is 37.02%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Mizuho cut their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price objective for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft dropped their target price on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research report on Wednesday, May 14th. Truist Financial reissued a “buy” rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, TD Securities reaffirmed a “hold” rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $426.52.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.